Arthur Kuan - 12 Mar 2026 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CGON
Reported as of: 12 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Mar 2026, 16:09:24 UTC
Prior SEC filing: 06 Mar 2026
Next SEC filing: 16 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Joshua F. Patterson, Attorney-in-Fact for Arthur Kuan

Key filing fact

Arthur Kuan filed Form 4 for CG Oncology, Inc. (CGON) on 13 Mar 2026.

Key facts

This page summarizes Arthur Kuan's Form 4 filing for CG Oncology, Inc. (CGON).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Mar 2026, 16:09.

Change

Previous filing in this sequence was filed on 06 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002007101 Primary reporting owner

Kuan Arthur

Relationship: Chief Executive Officer, Director
Address: C/O CG ONCOLOGY, INC., 400 SPECTRUM CENTER DRIVE, SUITE 2040, IRVINE
Signature: /s/ Joshua F. Patterson, Attorney-in-Fact for Arthur Kuan
Signature date: 13 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGON transaction

Common Stock

Options Exercise

Transaction value
Shares: +64,612
Change %: +47%
Price: $1.72^*
Shares after: 200,763
Date: 12 Mar 2026
Ownership: Direct

CGON transaction

Common Stock

Tax liability

Transaction value
Shares: -1,847
Change %: -0.92%
Price: $60.15^*
Shares after: 198,916
Date: 12 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGON transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -64,612
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 12 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 64,612
Exercise price: $1.72
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a "net exercise" of outstanding stock options. The reporting person received 62,765 shares of common stock on net exercise of an option to purchase 64,612 shares of common stock. The Company withheld 1,847 shares of common stock underlying the option and the reporting person paid in cash the delta for payment in full of the aggregate exercise price. This transaction does not represent a sale by the reporting person.

Footnote F2

The stock option is currently vested and exercisable.